| Document and Entity Information | 12 Months Ended |
| Dec. 31, 2023 | |
| Cover [Abstract] | |
| Document Type | PRE 14A |
| Amendment Flag | false |
| Entity Registrant Name | AMERICAN WELL CORPORATION |
| Entity Central Index Key | 0001393584 |
| Pay vs Performance Disclosure - USD ($) | 12 Months Ended | |||
| Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
| Pay vs Performance Disclosure | ||||
| Pay vs Performance Disclosure, Table | PAY VERSUS PERFORMANCE As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation and certain financial performance of our Company. The disclosure included in this section is prescribed by SEC rules and does not necessarily align with how the Company or the Committee view the link between the Company’s performance and its NEOs' pay. For additional information on our compensation programs and philosophy and how we design our compensation programs to align pay with performance, see the section titled “Compensation Discussion and Analysis." The table below presents information on the compensation of our chief executive officer(s) and our other NEOs in comparison to certain performance metrics for 2023, 2022, 2021 and 2020: Summary compensation table total for first PEO Summary compensation table total for second PEO (2)(3) Compensation actually paid to first PEO Compensation actually paid to second PEO (2)(3) Average summary compensation table total for non-PEO NEOs Average summary compensation actually paid for non-PEO NEOs (2)(3) Value of fixed $100 investment based on: Net Income Revenue Year Total shareholder return (4) S&P 500 healthcare services total shareholder return (5) 2023 $ 797,800 $ 658,400 $ ( 9,131,552 ) $ ( 9,270,952 ) $ 3,081,641 $ 22,839 $ 6 $ 157 $ ( 679,200,000 ) $ 259,047,000 2022 $ 16,161,230 $ 16,044,010 $ 7,075,701 $ 6,958,481 $ 6,417,175 $ 2,418,932 $ 12 $ 170 $ ( 272,100,000 ) $ 277,190,000 2021 $ 39,988,708 $ 39,940,379 $ ( 26,819,435 ) $ ( 26,867,764 ) $ 5,756,009 $ ( 3,538,060 ) $ 26 $ 162 $ ( 176,800,000 ) $ 252,789,000 2020 $ 69,253,101 $ 69,247,314 $ 96,113,239 $ 96,107,452 $ 9,574,620 $ 21,760,358 $ 110 $ 119 $ ( 228,600,000 ) $ 245,265,000 (1) Amwell's first principal executive officer for FY2020 through FY 2023 was Dr. Ido Schoenberg . Amwell's second principal executive officer for FY2020 through FY 2023 was Dr. Roy Schoenberg . Amwell's other, non-PEO, NEOs for FY2020 were Ms. Gotlib, Kurt Knight, and Mr. Anderson. Amwell's other, non-PEO, NEOs for FY2021 were Ms. Gotlib, Mr. Shepardson, Mr. Knight, Mr. O'Grady, and Mr. Anderson. Amwell's other, non-PEO, NEOs for FY2022 were Ms. Gotlib, Mr. Shepardson, Mr. Knight, and Mr. Paunovich. Amwell's other, non-PEO, NEOs for FY2023 were Ms. Gotlib, Mr. Shepardson, Mr. Paunovich and Ms. Weiler. (2) The below tables represent the compensation actually paid calculation detail: First PEO - Ido Schoenberg Second PEO - Roy Schoenberg NON-PEO NEOs Compensation Element 2023 2023 2023 SCT Reported Total Compensation $ 797,800 $ 658,400 $ 3,081,641 (i) Aggregate SCT Reported Equity Compensation (-) $ - $ - $ 2,589,350 (ii) Year-End Fair Value of Awards Granted During the FY & Outstanding (+) $ - $ - $ 974,050 (iii) Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Outstanding (+) $ ( 9,435,970 ) $ ( 9,435,970 ) $ ( 1,668,172 ) (iv) Vesting Date Fair Value of Awards Granted & Vested During the Covered FY (+) $ - $ - $ 336,607 (v) Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Vesting During Covered FY (+) $ ( 493,382 ) $ ( 493,382 ) $ ( 111,937 ) (vi) Prior FYE Value of Awards Determined to Fail to Meet Vesting Conditions During Covered FY (-) $ - $ - $ - Compensation Actually Paid Determination $ ( 9,131,552 ) $ ( 9,270,952 ) $ 22,839 (3) Equity compensation fair value calculated based on assumptions determined in accordance with FASB ASC Topic 718. (4) Total shareholder return calculated based on an assumed $100 investment as of 09/17/2020 and the reinvestment of any issued dividends. (5) The peer group reflected in the tables above is the S&P 500 Health Care Services index total shareholder return calculated based on an assumed $100 investment as of 09/17/2020 and the reinvestment of any issued dividends. | |||
| Named Executive Officers, Footnote | (1) Amwell's first principal executive officer for FY2020 through FY 2023 was Dr. Ido Schoenberg . Amwell's second principal executive officer for FY2020 through FY 2023 was Dr. Roy Schoenberg . Amwell's other, non-PEO, NEOs for FY2020 were Ms. Gotlib, Kurt Knight, and Mr. Anderson. Amwell's other, non-PEO, NEOs for FY2021 were Ms. Gotlib, Mr. Shepardson, Mr. Knight, Mr. O'Grady, and Mr. Anderson. Amwell's other, non-PEO, NEOs for FY2022 were Ms. Gotlib, Mr. Shepardson, Mr. Knight, and Mr. Paunovich. Amwell's other, non-PEO, NEOs for FY2023 were Ms. Gotlib, Mr. Shepardson, Mr. Paunovich and Ms. Weiler. | |||
| Peer Group Issuers, Footnote | (5) The peer group reflected in the tables above is the S&P 500 Health Care Services index total shareholder return calculated based on an assumed $100 investment as of 09/17/2020 and the reinvestment of any issued dividends. | |||
| Non-PEO NEO Average Total Compensation Amount | $ 3,081,641 | $ 6,417,175 | $ 5,756,009 | $ 9,574,620 |
| Non-PEO NEO Average Compensation Actually Paid Amount | $ 22,839 | 2,418,932 | (3,538,060) | 21,760,358 |
| Equity Valuation Assumption Difference, Footnote | (3) Equity compensation fair value calculated based on assumptions determined in accordance with FASB ASC Topic 718. | |||
| Compensation Actually Paid vs. Total Shareholder Return | Compensation Actually Paid vs TSR | |||
| Compensation Actually Paid vs. Net Income | Compensation Actually Paid vs Net Income | |||
| Compensation Actually Paid vs. Company Selected Measure | Compensation Actually Paid vs Adj EBITDA | |||
| Tabular List, Table | Provided below are the most important financial measures used to link compensation actually paid with Amwell performance during the most recently completed fiscal year: Revenue Stock Price Milestones Subscription Bookings | |||
| Total Shareholder Return Amount | $ 6 | 12 | 26 | 110 |
| Peer Group Total Shareholder Return Amount | 157 | 170 | 162 | 119 |
| Net Income (Loss) | $ (679,200,000) | (272,100,000) | (176,800,000) | (228,600,000) |
| Adjustment to PEO and Non PEO Compensation Footnote [Text Block] | (2) The below tables represent the compensation actually paid calculation detail: First PEO - Ido Schoenberg Second PEO - Roy Schoenberg NON-PEO NEOs Compensation Element 2023 2023 2023 SCT Reported Total Compensation $ 797,800 $ 658,400 $ 3,081,641 (i) Aggregate SCT Reported Equity Compensation (-) $ - $ - $ 2,589,350 (ii) Year-End Fair Value of Awards Granted During the FY & Outstanding (+) $ - $ - $ 974,050 (iii) Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Outstanding (+) $ ( 9,435,970 ) $ ( 9,435,970 ) $ ( 1,668,172 ) (iv) Vesting Date Fair Value of Awards Granted & Vested During the Covered FY (+) $ - $ - $ 336,607 (v) Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Vesting During Covered FY (+) $ ( 493,382 ) $ ( 493,382 ) $ ( 111,937 ) (vi) Prior FYE Value of Awards Determined to Fail to Meet Vesting Conditions During Covered FY (-) $ - $ - $ - Compensation Actually Paid Determination $ ( 9,131,552 ) $ ( 9,270,952 ) $ 22,839 | |||
| Revenue | $ 259,047,000 | 277,190,000 | 252,789,000 | 245,265,000 |
| Measure:: 1 | ||||
| Pay vs Performance Disclosure | ||||
| Name | Revenue | |||
| Measure:: 2 | ||||
| Pay vs Performance Disclosure | ||||
| Name | Stock Price Milestones | |||
| Measure:: 3 | ||||
| Pay vs Performance Disclosure | ||||
| Name | Subscription Bookings | |||
| Ido Schoenberg [Member] | ||||
| Pay vs Performance Disclosure | ||||
| PEO Total Compensation Amount | $ 797,800 | 16,161,230 | 39,988,708 | 69,253,101 |
| PEO Actually Paid Compensation Amount | $ (9,131,552) | $ 7,075,701 | $ (26,819,435) | $ 96,113,239 |
| PEO Name | Dr. Ido Schoenberg | Dr. Ido Schoenberg | Dr. Ido Schoenberg | Dr. Ido Schoenberg |
| Roy Schoenberg [Member] | ||||
| Pay vs Performance Disclosure | ||||
| PEO Total Compensation Amount | $ 658,400 | $ 16,044,010 | $ 39,940,379 | $ 69,247,314 |
| PEO Actually Paid Compensation Amount | $ (9,270,952) | $ 6,958,481 | $ (26,867,764) | $ 96,107,452 |
| PEO Name | Dr. Roy Schoenberg | Dr. Roy Schoenberg | Dr. Roy Schoenberg | Dr. Roy Schoenberg |
| PEO | Ido Schoenberg [Member] | Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Outstanding [Member] | ||||
| Pay vs Performance Disclosure | ||||
| Adjustment to Compensation, Amount | $ (9,435,970) | |||
| PEO | Ido Schoenberg [Member] | Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Vesting During Covered FY [Member] | ||||
| Pay vs Performance Disclosure | ||||
| Adjustment to Compensation, Amount | (493,382) | |||
| PEO | Roy Schoenberg [Member] | Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Outstanding [Member] | ||||
| Pay vs Performance Disclosure | ||||
| Adjustment to Compensation, Amount | (9,435,970) | |||
| PEO | Roy Schoenberg [Member] | Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Vesting During Covered FY [Member] | ||||
| Pay vs Performance Disclosure | ||||
| Adjustment to Compensation, Amount | (493,382) | |||
| Non-PEO NEO | Aggregate SCT Reported Equity Compensation [Member] | ||||
| Pay vs Performance Disclosure | ||||
| Adjustment to Compensation, Amount | 2,589,350 | |||
| Non-PEO NEO | Year-End Fair Value of Awards Granted During the FY & Outstanding [Member] | ||||
| Pay vs Performance Disclosure | ||||
| Adjustment to Compensation, Amount | 974,050 | |||
| Non-PEO NEO | Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Outstanding [Member] | ||||
| Pay vs Performance Disclosure | ||||
| Adjustment to Compensation, Amount | (1,668,172) | |||
| Non-PEO NEO | Vesting Date Fair Value of Awards Granted & Vested During the Covered FY [Member] | ||||
| Pay vs Performance Disclosure | ||||
| Adjustment to Compensation, Amount | 336,607 | |||
| Non-PEO NEO | Year-Over-Year Change in Fair Value of Awards Granted During Prior FY & Vesting During Covered FY [Member] | ||||
| Pay vs Performance Disclosure | ||||
| Adjustment to Compensation, Amount | $ (111,937) | |||
